![]() |
市場調查報告書
商品編碼
1802960
全球土壤微生物基因組學市場:2032 年預測 - 按技術、應用、最終用戶和地區分析Soil Microbial Genomics Market Forecasts to 2032 - Global Analysis By Technology (Next-Generation Sequencing, Polymerase Chain Reaction-based Methods, Microarrays and Other Technologies), Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球土壤微生物基因組學市場預計在 2025 年達到 2.698 億美元,預計到 2032 年將達到 6.508 億美元,預測期內的複合年成長率為 13.4%。
土壤微生物基因組學是研究土壤生態系統中多種微生物遺傳物質的學科,旨在了解微生物的功能、相互作用及其在養分循環、土壤肥力和環境永續性中的作用。我們利用定序技術和生物資訊學,揭示微生物多樣性、代謝途徑及其對環境變化的反應。該領域支持農業、碳管理和生物修復領域的進步,最佳化土壤健康,並為應對糧食安全和氣候變遷適應力等全球挑戰提供關鍵見解。
根據ScienceDirect報告,一項使用GeoChip資料的研究從土壤微生物功能基因資料集中識別出總合946個基因、4,342個分類單元、102個門和995個屬。
對永續農業的需求不斷增加
全球對永續農業的日益關注,從根本上推動了土壤微生物基因組學市場的擴張。農民和農業相關人員越來越認知到,土壤微生物是作物產量、養分循環和生態系統健康的關鍵決定因素。監管壓力和消費者對環保農業實踐的需求,迫使農民採用以微生物為基礎的解決方案。此外,有益土壤微生物已被證實能夠提高作物產量,同時減少對化學肥料的依賴,這吸引了公共和私營部門的大量投資,從而刺激了市場成長。
缺乏標準化通訊協定
缺乏普遍接受的土壤微生物基因體學標準通訊協定是市場發展的一大限制。這項限制導致不同實驗室和研究機構在資料收集、處理方法和結果解讀方面存在不一致。標準化的缺乏阻礙了研究結果的有效比較,並限制了商業性應用的擴充性。此外,監管機構面臨在沒有明確行業標準的情況下建立核准框架的挑戰,導致產品開發進度緩慢,市場滲透率低。
精密農業一體化
先進的數據分析平台與即時土壤監測系統相結合,如今可以處理複雜的基因組資料集,並為農民提供切實可行的微生物組洞察。人工智慧、物聯網感測器和基因組序列測定的融合,使得特異性地點的微生物干預措施能夠最佳化作物產量。此外,這種技術協同效應將促進土壤健康管理預測模型的開發,為農業科技公司創造新的收益來源,並提高基於基因組的農業解決方案的經濟可行性。
基因序列測定和數據分析高成本
小農戶和開發中地區通常無法承擔全面土壤微生物基因組評估的高前期成本。對專業生物資訊學專業知識和計算資源的需求造成了持續的營運成本,並限制了市場准入。此外,定序技術的快速發展使得設備需要頻繁升級,進一步增加了整體擁有成本。這種經濟障礙可能會限制市場滲透,並將利潤集中在資金雄厚的農業公司手中。
新冠疫情最初導致供應鏈中斷和農業研究資金減少,阻礙了土壤微生物基因組學市場的成長。實驗室關閉和田間作業受限,嚴重推遲了正在進行的研究和產品開發進度。然而,這場危機隨後激發了人們對糧食安全和永續農業的興趣,促使農業生物技術投資增加。此外,政府獎勵策略還包括對農業創新的資金支持,部分抵消了疫情初期的衝擊。疫情最終凸顯了韌性糧食生產系統的重要性,並為以土壤微生物為基礎的解決方案創造了長期機會。
預計次世代定序儀(NGS)細分市場在預測期內將佔據最大佔有率
預計次世代定序(NGS) 領域將在預測期內佔據最大市場佔有率,這得益於其相比傳統定序方法更卓越的分析能力和成本效益。 NGS 平台能夠同時高通量處理多個樣本,從而實現全面的土壤微生物組分析,使大規模農業應用具有經濟可行性。此外,定序成本的下降和方便用戶使用型 NGS 系統的日益普及,使得農業研究人員和商業相關人員能夠輕鬆獲得先進的基因組分析能力。
預計農業化學品和農業相關企業部門在預測期內將見證最高的複合年成長率。
隨著越來越多的公司認知到土壤微生物基因組學是競爭優勢,農化及農業相關企業領域預計將在預測期內實現最高成長率。領先的農化公司正在將微生物組分析納入其產品開發平臺,以創造更有針對性、更有效的農業解決方案。此外,向生技藥品和永續農作物保護產品的轉變正在推動微生物基因組學研究的大量研發投入。此外,領先的農化公司與基因組學相關企業之間的策略聯盟正在加速創新週期和市場滲透,從而推動該領域的強勁成長動能。
預計北美將在預測期內佔據最大的市場佔有率,這得益於其發達的農業研究基礎設施和較高的技術採用率。該地區受益於政府對農業生物技術研究的大量資助,以及由基因組學公司和學術機構組成的強大生態系統。在有利的法規結構和完善的精密農業的支持下,北美農民積極採用創新農業技術。此外,大型農業化學品和生物技術公司的存在為土壤微生物基因組學的商業化和廣泛的市場認可創造了有利環境。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這得益於其農業部門的快速擴張以及政府對永續農業計畫的支持力度不斷增加。人口壓力和日益成長的糧食安全擔憂,正在推動該地區對農業創新和提高生產力技術的投資。此外,研究基礎設施的改善以及亞洲農民對土壤健康重要性的認知不斷提高,也創造了有利的市場條件。國際基因組學公司與本地農業組織之間日益增多的合作,正在加速技術轉移和市場開發,使亞太地區成為最具活力的成長地區。
According to Stratistics MRC, the Global Soil Microbial Genomics Market is accounted for $269.8 million in 2025 and is expected to reach $650.8 million by 2032 growing at a CAGR of 13.4% during the forecast period. Soil microbial genomics is the study of genetic material from diverse microorganisms in soil ecosystems to understand their functions, interactions, and roles in nutrient cycling, soil fertility, and environmental sustainability. By leveraging sequencing technologies and bioinformatics, it reveals microbial diversity, metabolic pathways, and responses to environmental changes. This field supports advancements in agriculture, carbon management, and bioremediation, offering critical insights for optimizing soil health and addressing global challenges in food security and climate resilience.
According to ScienceDirect, studies using GeoChip data detected a total of 946 genes, 4,342 taxa, 102 phyla, and 995 genera in soil microbial functional gene datasets.
Growing demand for sustainable agriculture
The escalating global focus on sustainable agricultural practices is fundamentally driving the soil microbial genomics market expansion. Farmers and agricultural stakeholders increasingly recognize soil microbiomes as critical determinants of crop productivity, nutrient cycling, and ecosystem health. Regulatory pressures and consumer demands for environmentally responsible farming methods are compelling agricultural producers to adopt microbiome-based solutions. Moreover, the proven ability of beneficial soil microorganisms to reduce chemical fertilizer dependency while enhancing crop yields is attracting significant investment from both public and private sectors, thereby accelerating market growth.
Lack of standardized protocols
The absence of universally accepted standardized protocols for soil microbial genomics is a significant market restraint. This limitation creates inconsistencies in data collection, processing methodologies, and result interpretation across different laboratories and research institutions. The lack of standardization hampers effective comparison of research findings and limits the scalability of commercial applications. Moreover, regulatory bodies face challenges in establishing approval frameworks without clear industry standards, consequently slowing product development timelines and market adoption rates.
Precision agriculture integration
Advanced data analytics platforms can now process complex genomic datasets alongside real-time soil monitoring systems to provide farmers with actionable microbiome insights. The convergence of artificial intelligence, IoT sensors, and genomic sequencing enables site-specific microbial interventions that optimize crop performance. Moreover, this technological synergy facilitates the development of predictive models for soil health management, creating new revenue streams for agricultural technology companies and enhancing the economic viability of genomic-based farming solutions.
High cost of genomic sequencing & data analysis
Small-scale farmers and developing regions often cannot justify the high upfront costs associated with comprehensive soil microbial genomic assessments. The need for specialized bioinformatics expertise and computational resources creates ongoing operational expenses that limit market accessibility. Moreover, the rapid evolution of sequencing technologies necessitates frequent equipment upgrades, further escalating total ownership costs. This economic barrier restricts market penetration and potentially concentrates benefits among well-funded agricultural enterprises.
The COVID-19 pandemic initially disrupted soil microbial genomics market growth through supply chain interruptions and reduced agricultural research funding. Laboratory closures and restricted fieldwork significantly delayed ongoing studies and product development timelines. However, the crisis subsequently accelerated interest in food security and sustainable agriculture, driving increased investment in agricultural biotechnology. Additionally, government stimulus packages included funding for agricultural innovation, partially offsetting initial setbacks. The pandemic ultimately highlighted the importance of resilient food production systems, creating long-term opportunities for soil microbiome-based solutions.
The next-generation sequencing (NGS) segment is expected to be the largest during the forecast period
The next-generation sequencing (NGS) segment is expected to account for the largest market share during the forecast period due to its superior analytical capabilities and cost-effectiveness compared to traditional sequencing methods. NGS platforms enable comprehensive soil microbiome profiling through high-throughput processing of multiple samples simultaneously, making large-scale agricultural applications economically viable. Moreover, declining sequencing costs and increasing availability of user-friendly NGS systems are democratizing access to advanced genomic analysis capabilities for agricultural researchers and commercial stakeholders.
The agrochemical and agricultural companies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the agrochemical and agricultural companies segment is predicted to witness the highest growth rate as these organizations increasingly recognize soil microbial genomics as a competitive differentiator. Leading agrochemical corporations are integrating microbiome analysis into their product development pipelines to create more targeted and effective agricultural solutions. Additionally, the shift toward biologics and sustainable crop protection products is driving substantial R&D investments in microbial genomics research. Moreover, strategic partnerships between agrochemical giants and genomics companies are accelerating innovation cycles and market penetration, positioning this segment for exceptional growth momentum.
During the forecast period, the North America region is expected to hold the largest market share, driven by substantial agricultural research infrastructure and advanced technological adoption rates. The region benefits from significant government funding for agricultural biotechnology research and a robust ecosystem of genomics companies and academic institutions. North American farmers demonstrate higher willingness to adopt innovative agricultural technologies, supported by favorable regulatory frameworks and established precision agriculture practices. Moreover, the presence of major agrochemical corporations and biotechnology firms creates conducive environment for soil microbial genomics commercialization and widespread market acceptance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to rapidly expanding agricultural sectors and increasing government support for sustainable farming initiatives. Growing population pressures and food security concerns are driving regional investments in agricultural innovation and productivity enhancement technologies. Additionally, improving research infrastructure and rising awareness of soil health importance among Asian farmers are creating favorable market conditions. The increasing collaboration between international genomics companies and local agricultural organizations is accelerating technology transfer and market development, positioning Asia Pacific as the most dynamic growth region.
Key players in the market
Some of the key players in Soil Microbial Genomics Market include Novozymes, Bayer, BASF, Corteva, Syngenta, Marrone Bio Innovations, Certis Biologicals, Indigo Ag, AgBiome, Pivot Bio, Ginkgo Bioworks, BioConsortia, Chr. Hansen, Valent BioSciences, Evogene, and Lallemand.
In November 2022, BASF has expanded R&D on biodegradability and soil microbial interactions. Their research advances developing biodegradable products like mulch films that break down in soil via microbial action. They collaborate extensively to understand and improve how materials biodegrade in soil and wastewater treatment systems, aiming to support sustainable agriculture and reduce environmental impact.
In October 2022, Corteva entered a multi-year European distribution agreement with STI Biotechnologie to bring Lactobacillus strains-based biostimulants (Utrisha(TM) Rhizo) to market. These microbial products enhance soil and rhizosphere health, supporting crop resilience and nutrient uptake under varied conditions. Corteva's biologicals pipeline emphasizes sustainable innovation and natural-origin solutions.
Table 13 Global Soil Microbial Genomics Market Outlook, By Other Technologies (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.